Both modified cognitive behavioral therapy (CBT) and pain education (EDU) interventions were associated with improved pain in patients with disadvantaged backgrounds.
Mortality rates decreased for alcohol use disorders, self-harm, and interpersonal violence between 1980 and 2014. Mortality rates for drug use disorders increased both nationally and in each county over the same period.
Package inserts of opioid analgesics may not consistently provide information regarding safe drug storage and/or disposal.
A longer duration of extended-release naltrexone treatment in individuals with opioid dependence was associated with improved outcomes and reduced rates of relapse.
Researchers calculated age-standardized mortality rates on a county level in the United States between 1980 and 2014, specifically examining rates for self-harm, interpersonal violence, alcohol use, and drug use.
While results so far may seem to support a link between increased access to cannabis and a reduction in prescription opioid use, findings from a study published in 2018 found otherwise.
All 3 opioid-dependence pharmacotherapies — methadone, buprenorphine, and oral naltrexone — were associated with reductions in inpatient substance abuse treatment.
Antidepressant medication adherence is linked with cessation of opioid use.
Prescription opioids kept in the household may increase the risk for opioid initiation in co-residents.
Methadone exposure in utero was shown to have an increased risk of neonatal abstinence syndrome compared with buprenorphine.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- #MeToo: Helping Victims Cope With Sexual Harassment
- Clinician Insight: Exploring the Link Between Bipolar Disorder and Binge Eating Disorder
- Association Between Psychosis and Development of Dementia in Older Men
- Psychosis Could Be a Potential Side Effect of Steroid Treatment in Kids
- Effects of Antipsychotic Drugs on the Cardiovascular System
- Triiodothyronine in the Treatment of Bipolar Depression
- Nutritional Influences on Bipolar Disorder in Children
- Old Challenges and New Directions in Managing Tardive Dyskinesia
- Similar Rates of Childhood Trauma in Schizophrenia and Substance Use Disorders
- Potential for SERMs as Adjunctive Therapy for Schizophrenia
- Psychiatric Comorbidities Increase Neurologic Disability in Multiple Sclerosis
- Self-Regulation Interventions Beneficial for Children
- Traumatic Brain Injury Associated With Increased Risk for Dementia
- Adverse Neurodevelopmental and Mental Health Outcomes in PCOS
- Depression and Sleep Disturbances: Common Bedfellows